Primary human hepatocytes have become the “gold standard” for evaluating hepatic metabolism and toxicity of drugs and other xenobiotics in vitro. Moreover, they are becoming utilized more extensively for many kinds of biomedical research, including a variety of biological, pharmacological and toxicological studies. For this reason, while we are living through this health crisis due to the spread of COVID-19 disease, hepatocytes are key to drug testing with the goal of mitigating the detrimental effects that this disease involves.

Until 31^th of August, Cytes Biotechnology will offer 3D Spheroid qualified Human Hepatocytes at 2D price.

In our aim to support the global research community against COVID-19 pandemic, making available our 3D Spheroid qualified primary human hepatocytes at 2D price for a longer period. 

Spheroids are part of the cutting-edge of 3D hepatic cell culture which provide the best cellular functional lever for physiology and pathological studies, as well as drug discovery and toxicology with high predictive value